TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30958567

Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD) and citric acid decontamination (CAD)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD), citric acid decontamination (CAD) and subepithelial connective tissue graft (SCTG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD), citric acid decontamination (CAD) and implantoplasty
Number of subjects: 23
Study: 30150192

Group type: EXPERIMENTAL
Intervention: Garlic powder (GP) at a dose rate of 2 g/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Coriander seed powder (CSP) at a dose rate of 2 g/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mixture of garlic powder and coriander seed powder (1:1 dry weight basis) at a dose rate of 2 g/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 26219667

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard exercise (EXE)
Number of subjects: 27
Study: 25390871

Group type: EXPERIMENTAL
Intervention: Acrylic resin-based resilient liner (ARL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional acrylic resin denture (CARD)
Number of subjects: 74
Study: 22161771

Group type: EXPERIMENTAL
Intervention: EGFR-TKI (Gefitinib or Erlotinib)
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Chemotherapy (platinum-based doublet)
Number of subjects: 1021
Study: 19351383

Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 240

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 240
Study: 17725303

Group type: EXPERIMENTAL
Intervention: Vardenafil (10 mg to 20 mg for 2 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sertraline (50 mg daily for 2 months)
Number of subjects: 60
Study: 17021414

Group type: EXPERIMENTAL
Intervention: 4-line Cobb method for measuring lumbar lordosis
Number of subjects: 109
Study: 15470715

Group type: EXPERIMENTAL
Intervention: Sequential irinotecan plus bolus 5‐FU/LV (Arm B)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus bolus 5‐FU/LV (Arm E)
Number of subjects: 108
Study: 10579705

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8914949

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil capsules containing 1.5-1.8 g of DHA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control oil capsules containing 97% soybean oil and 3% fish oil
Number of subjects: 24
Study: 1830565

Group type: EXPERIMENTAL
Intervention: Chlorprothixene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 6336865

Group type: COMPARATOR
Intervention: Clindamycin + Tobramycin (C + T)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Metronidazole + Tobramycin (M + T)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Metronidazole + Tobramycin (M + T) in second phase
Number of subjects: 102
Study: 30773058

Group type: EXPERIMENTAL
Intervention: Exercise intervention of ≥150 min of moderate-intensity activity per week
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 41
Study: 31477161

Group type: EXPERIMENTAL
Intervention: Febuxostat 20 mg daily
Number of subjects: 240

Group type: COMPARATOR
Intervention: Benzbromarone 25 mg daily
Number of subjects: 240
Study: 29259061

Group type: EXPERIMENTAL
Intervention: Guided physical exercise and dietary therapy
Number of subjects: 10
Study: 26443050

Group type: EXPERIMENTAL
Intervention: Hallucinations
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Drug use
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Negative symptoms
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Suspiciousness/Persecution
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Anxiety, Depression, and Hopelessness
Number of subjects: 124
Study: 24028237

Group type: EXPERIMENTAL
Intervention: Message about health consequences of childhood obesity
Number of subjects: 2494

Group type: EXPERIMENTAL
Intervention: Message about military readiness consequences of childhood obesity
Number of subjects: 2494

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2494
Study: 21719618

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 407

Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Duloxetine plus gabapentin
Number of subjects: 407
Study: 19539255

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 270
Study: 16982294

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg QD for 5 days
Number of subjects: 369

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 875 mg/125 mg BID for 10 days
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 369

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 369
Study: 12740545

Group type: EXPERIMENTAL
Intervention: Carisolv method
Number of subjects: 22

Group type: COMPARATOR
Intervention: Rose-bur method
Number of subjects: 22
Study: 11026118

Group type: EXPERIMENTAL
Intervention: Computer-based examination
Number of subjects: 30

Group type: COMPARATOR
Intervention: Paper-based examination
Number of subjects: 30
Study: 9333066

Group type: EXPERIMENTAL
Intervention: Cefodizime (single 2‐g intravenous dose)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single 2‐g intravenous dose)
Number of subjects: 42
Study: 8265839

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg q.d.s.)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sodium cromoglycate (10 mg q.d.s.)
Number of subjects: 77
Study: 3908417

Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (experimental counseled)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (experimental uncounseled)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group (counseled)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Control group (uncounseled)
Number of subjects: 410
Study: 30782982

Group type: EXPERIMENTAL
Intervention: Doravirine with elbasvir-grazoprevir
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Doravirine with ledipasvir-sofosbuvir
Number of subjects: 26
Study: 29250742

Group type: EXPERIMENTAL
Intervention: Apatorsen + Prednisone
Number of subjects: 74

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 74
Study: 26321218

Group type: EXPERIMENTAL
Intervention: Inhaled Alpha‐1 HC 100 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inhaled Alpha‐1 HC 200 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23890273

Group type: EXPERIMENTAL
Intervention: Group 1: Pegylated interferon (160 μg weekly) + Ribavirin (1200 mg if ≥ 75 kg, 1000 mg if <75 kg) for 48 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Group 2: Nitazoxanide (500 mg bid for 4 weeks lead-in) + Pegylated interferon + Ribavirin for 48 weeks
Number of subjects: 100
Study: 22339573

Group type: EXPERIMENTAL
Intervention: Rolofylline 30 mg
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2002
Study: 20357761

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 22

Group type: COMPARATOR
Intervention: Valproic acid (VPA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy comparison subjects
Number of subjects: 22
Study: 18287126

Group type: EXPERIMENTAL
Intervention: Adenosine 5′-monophosphate (AMP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Methacholine (MCh)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 36
Study: 16599102

Group type: EXPERIMENTAL
Intervention: Intensive nutrition education (INE) twice a week for three months
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Intensive nutrition education with supplementary feeding (INE+SF) twice a week for three months
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard routine nutrition education from community nutrition promoters twice a month
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Intensive nutrition education (INE)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Intensive nutrition education with supplementary feeding (INE+SF)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard routine nutrition education
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Both intervention groups (INE and INE+SF)
Number of subjects: 282
Study: 11811507

Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 20
Study: 9732938

Group type: EXPERIMENTAL
Intervention: Dual therapy: Lansoprazole (30 mg b.i.d.) and Amoxicillin (1 g b.i.d.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Triple therapy: Lansoprazole (30 mg b.i.d.), Amoxicillin (1 g b.i.d.), and Clarithromycin (500 mg b.i.d.)
Number of subjects: 50
Study: 7964858

Group type: EXPERIMENTAL
Intervention: IVIg treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2525998

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + Hydrochlorothiazide 25 mg (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amiloride 5 mg + Hydrochlorothiazide 50 mg (group B)
Number of subjects: 40
Study: 12608175

Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 17

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 17
Study: 31937614

Group type: EXPERIMENTAL
Intervention: Radium-223 plus enzalutamide (RE)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Enzalutamide alone
Number of subjects: 39
Study: 30730356

Group type: EXPERIMENTAL
Intervention: Couples-based intervention including one group session (3-4 hours) and 4 counseling sessions (1-2 hours) focusing on communication skills, intimate partner violence, and HIV prevention.
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 334
Study: 27855739

Group type: EXPERIMENTAL
Intervention: Polyvinylidene fluoride (PVDF) belts
Number of subjects: 50

Group type: COMPARATOR
Intervention: Respiratory inductance plethysmography (RIP) belts
Number of subjects: 50
Study: 24997175

Group type: EXPERIMENTAL
Intervention: Targeted education strategies to increase delivery of early enteral nutrition
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard ad hoc practice
Number of subjects: 121
Study: 23299978

Group type: EXPERIMENTAL
Intervention: LHW intervention addressing HBV
Number of subjects: 250

Group type: COMPARATOR
Intervention: LHW intervention addressing physical activity
Number of subjects: 250
Study: 21967302

Group type: EXPERIMENTAL
Intervention: Microfluidic platforms for compartmentalization of neurons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional methods for compartmentalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compartmentalized microfluidic platforms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological manipulation and electrical stimulation of synapses
Number of subjects: 0
Study: 18331175

Group type: EXPERIMENTAL
Intervention: Bipolar sealer device
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard electrocautery
Number of subjects: 50
Study: 16823832

Group type: EXPERIMENTAL
Intervention: Intermittent pedicle occlusion with ischaemic interval of 15 minutes (SG)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Intermittent pedicle occlusion with ischaemic interval of 30 minutes (PG)
Number of subjects: 108
Study: 12624286

Group type: EXPERIMENTAL
Intervention: NAA concentration in the symptomatic hemisphere
Number of subjects: 19

Group type: COMPARATOR
Intervention: NAA concentration in the contralateral hemisphere
Number of subjects: 19

Group type: COMPARATOR
Intervention: NAA concentration in control subjects
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NAA concentration in patients with cerebral ischemia (symptomatic hemisphere)
Number of subjects: 19

Group type: COMPARATOR
Intervention: NAA concentration in patients with cerebral ischemia (asymptomatic hemisphere)
Number of subjects: 19
Study: 11083348

Group type: EXPERIMENTAL
Intervention: Six-week exercise program to improve aerobic capacity, muscular endurance, and flexibility.
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (individuals not treated for chronic pain)
Number of subjects: 258
Study: 8803642

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (enoxaparin 40 mg once daily)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily) plus graduated elastic compression (TEDR stockings) for 8-12 days
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (placebo injections)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients with DVT
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patients without DVT
Number of subjects: 78
Study: 1387231

Group type: EXPERIMENTAL
Intervention: 3 g fish oil preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6 g fish oil preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12 g fish oil preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dosages of fish oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dosages of fish oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both fish oil preparations
Number of subjects: 0
Study: 6436897

Group type: EXPERIMENTAL
Intervention: Haloperidol 16 mg per day (low dose)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Haloperidol 80 mg per day (high dose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study: 31965532

Group type: EXPERIMENTAL
Intervention: Self-managed, CBT-oriented exposure training delivered by the primary care practice team
Number of subjects: 419

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 419
Study: 29423774

Group type: EXPERIMENTAL
Intervention: Glucose levels above the median (11.5 mmol/L)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Patients with diabetes
Number of subjects: 513
Study: 26616224

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 administered over a 3 hour infusion, cycling every 21 days
Number of subjects: 31
Study: 25012645

Group type: EXPERIMENTAL
Intervention: Resistance training (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Passive physical therapy (group B)
Number of subjects: 60
Study: 23959190

Group type: EXPERIMENTAL
Intervention: HRV biofeedback
Number of subjects: 45

Group type: COMPARATOR
Intervention: Autogenic Training (AT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 45
Study: 20625187

Group type: EXPERIMENTAL
Intervention: Crushed ice ingestion (ICE)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Tap water (CON)
Number of subjects: 7
Study: 18619799

Group type: EXPERIMENTAL
Intervention: Dietary fiber therapy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 193
Study: 15944853

Group type: EXPERIMENTAL
Intervention: Forensic patients
Number of subjects: 79

Group type: COMPARATOR
Intervention: General psychiatric patients
Number of subjects: 79
Study: 14735032

Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (Group I)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 113
Study: 10231050

Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intrauterine insemination (IUI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion (meta-analysis)
Number of subjects: 0
Study: 8910627

Group type: EXPERIMENTAL
Intervention: HPV‐16 virus‐like particles (VLP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HPV‐16 E6 and E7 proteins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Any antigen preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High antibody titers
Number of subjects: 0
Study: 1869332

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiographic monitoring
Number of subjects: 40

Group type: COMPARATOR
Intervention: No echocardiographic monitoring
Number of subjects: 40
Study: 6873561

Group type: EXPERIMENTAL
Intervention: Propantheline bromide (anticholinergic agent)
Number of subjects: 10
Study: 2579597

Group type: EXPERIMENTAL
Intervention: Intraderma injection of terbutaline (0.25-100 ng)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral terbutaline and theophylline treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 38
Study: 28720423

Group type: EXPERIMENTAL
Intervention: Case-Based Teaching (CBT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bedside Teaching
Number of subjects: 96
Study: 27473676

Group type: EXPERIMENTAL
Intervention: Peer counseling intervention promoting exclusive breastfeeding (EBF) in addition to standard care
Number of subjects: 765

Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Peer counseling intervention promoting EBF
Number of subjects: 765
Study: 23991679

Group type: EXPERIMENTAL
Intervention: 1‐hour therapeutic play intervention plus routine care
Number of subjects: 106

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 106
Study: 22849416

Group type: EXPERIMENTAL
Intervention: Blind lineup administration (presumed blind condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-blind lineup administration (presumed nonblind condition)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inaccurate participants in presumed blind condition
Number of subjects: 0
Study: 21122147

Group type: EXPERIMENTAL
Intervention: Cold-pressed turnip rapeseed oil (CPTRO)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Butter
Number of subjects: 37
Study: 18780885

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CIMT after 4 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Experimental group (CIMT immediately after baseline)
Number of subjects: 30
Study: 15733876

Group type: EXPERIMENTAL
Intervention: Soft forceps
Number of subjects: 96

Group type: COMPARATOR
Intervention: Regular forceps
Number of subjects: 96
Study: 14520027

Group type: EXPERIMENTAL
Intervention: Fat-modified diet with caloric restriction and daily intake of 35-50 g oat bran
Number of subjects: 235

Group type: COMPARATOR
Intervention: Fat-modified, oat bran-free diet with caloric restriction
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (53 male overweight but normocholesterolemic subjects)
Number of subjects: 235
Study: 10655911

Group type: EXPERIMENTAL
Intervention: 8% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64

Group type: COMPARATOR
Intervention: Propofol 3-4 mg kg-1 with succinylcholine 2 mg kg-1
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 64

Group type: COMPARATOR
Intervention: Propofol-succinylcholine
Number of subjects: 64
Study: 8887260

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Prednisolone in combination with other immunosuppressants
Number of subjects: 929

Group type: COMPARATOR
Intervention: Various treatment protocols
Number of subjects: 929
Study: 1649265

Group type: EXPERIMENTAL
Intervention: Alternating regimen of methotrexate, etoposide, and cisplatin
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard treatment with cyclophosphamide, doxorubicin, and vincristine (CAV)
Number of subjects: 170
Study: 6226963

Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 38
Study: 30836957

Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on improving physical activity, including access to a gym, motivational counselling, and organized lunch walks.
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on reducing sedentary behavior, including standing- and walking meetings, motivational counselling, and encouragement to reduce sitting.
Number of subjects: 330

Group type: COMPARATOR
Intervention: Waiting list control group (passive control) that will receive the allocated intervention after a 6-month delay.
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Both interventions include 5 sessions of motivational counselling.
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Both interventions include measurements of cardiovascular fitness, body composition, sleep, self-reported physical activity and sedentary behavior, and other health habits.
Number of subjects: 330
Study: 30188085

Group type: EXPERIMENTAL
Intervention: Counselling (involving peer counsellors)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Socio-economic development (SED)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Contact between community members and affected people
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 237
Study: 26391623

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs), n = 5
Number of subjects: 13

Group type: COMPARATOR
Intervention: No antiarrhythmic drugs (AADs), n = 8
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Overall AF condition
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Overall SR condition
Number of subjects: 13
Study: 23234619

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21663809

Group type: EXPERIMENTAL
Intervention: Methylene blue (50 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lidocaine (40 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 90
Study: 19636011

Group type: EXPERIMENTAL
Intervention: rhITF 10 mg/mL (low dose)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: rhITF 80 mg/mL (high dose)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 16179822

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: HCV-negative asthmatics (control group)
Number of subjects: 41